Study details
Enrolling now
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Inova Health Care Services
NCT IDNCT06007846ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2/3
Target enrollment
12
Study length
about 3.1 years
Ages
18+
Locations
2 sites in VA
What this study is about
Researchers are testing whether memantine, a medication, can help patients with cirrhosis or liver cancer. The trial will last for 1127 days and involve approximately 12 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Namenda
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Patients Progression Free Survival at 6 months
Body systems
Gastroenterology